Tower Trust’s Novartis NVS Stock Holding History

Tower Trust’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	$644K	Hold	8,447	–	–	0.41%	72
2013 Q4	$608K	Hold	8,447	–	–	0.37%	76
2013 Q3	$581K	Sell	8,447 -223	-3%	-$14.8K	0.39%	72
2013 Q2	$550K	Buy	+8,670	New	+$564K	0.4%	73

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Tower Trust's NVS Position: Q1 2014 in Review

Tower Trust held its Novartis (NVS) position steady in Q1 2014 at 8,447 shares worth $644K. The position accounts for 0.41% of the portfolio, ranked #72.

Tower Trust first reported a position in NVS in Q2 2013 and has held it in 4 quarters since. 830 funds tracked by Wall St. Rank hold NVS as of Q1 2014.

Tower Trust held 8,447 shares of Novartis worth $644K as of Q1 2014.
Tower Trust left its Novartis share count unchanged in Q1 2014.
Novartis made up 0.41% of Tower Trust's portfolio in Q1 2014, its #72 holding.
Tower Trust first reported a position in Novartis in Q2 2013 and has held it in 4 quarters since.
830 funds tracked by Wall St. Rank held Novartis as of Q1 2014.

Based on Tower Trust's 13F filing for Q1 2014, filed 8 May 2014.